Skip to main content

Marta Torres Ferrús

Sóc Llicenciada en Medicina per la Universitat Autònoma de Barcelona. Em vaig especialitzar en Neurologia a l'Hospital Universitari Vall d'Hebron on continuo la meva activitat assistencial i investigadora a la Unitat de Cefalees del Servei de Neurologia.

Institutions of which they are part

Main researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca
Neurology
General Hospital
Marta Torres Ferrús

Marta Torres Ferrús

Marta Torres Ferrús

Institutions of which they are part

Main researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca
Neurology
General Hospital

Sóc Llicenciada en Medicina per la Universitat Autònoma de Barcelona. Em vaig especialitzar en Neurologia a l'Hospital Universitari Vall d'Hebron on continuo la meva activitat assistencial i investigadora a la Unitat de Cefalees del Servei de Neurologia.

Sóc membre de la "International Headache Society", Grup d'Estudi de Cefalees de la Societat Espanyola de Nerurologia (GECSEN) i de la Societat Catalana de Neurologia.
He rebut múltiples beques per a la realització de projectes de investigació. He publicat articles originals i de revisió i tinc experiència en la realització d'assajos clínics.

Projects

BiOmarcadores Moleculares y clínicos de respuesta al tratamiento en los Ataques de Migraña (Estudio MAMBO).

IP: Marta Torres Ferrús
Collaborators: Alicia Alpuente Ruiz, Laila Asskour, Eulalia Gine Cipres, Victor José Gallardo Lopez, Edoardo Caronna, Laura Gómez Dabó
Funding agency: Instituto de Salud Carlos III
Funding: 75020
Reference: PI22/01530
Duration: 01/01/2023 - 31/12/2025

Cefalea i dolor neurològic

IP: Patricia Pozo Rosich
Collaborators: Alicia Alpuente Ruiz, Laila Asskour, Eulalia Gine Cipres, Marta Torres Ferrús, Victor José Gallardo Lopez, Nara Ikumi Montserrat, Marta Vila Pueyo, Erika Ivanna Araya, Edoardo Caronna
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00406
Duration: 01/01/2022 - 30/06/2025

AhEAD: Algoritmo de predicción de Eficacia de respuesta A tratamiento preventivo en pacientes con migraña crónica: marcaDores biológicos y clínicos

IP: Patricia Pozo Rosich
Collaborators: Alicia Alpuente Ruiz, Eulalia Gine Cipres, Marta Torres Ferrús, Victor José Gallardo Lopez, Edoardo Caronna
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI19/01684
Duration: 01/01/2020 - 30/06/2024

BIOMIGA: un abordaje multidisciplinar para la identificacion de biomarcadores en migraña: estudio prueba de concepto basado en la estratificación de respondedores a anticuerpos monoclonales contra el CGRP

IP: Patricia Pozo Rosich
Collaborators: Alicia Alpuente Ruiz, Laila Asskour, Eulalia Gine Cipres, Marta Torres Ferrús, Victor José Gallardo Lopez
Funding agency: Instituto de Salud Carlos III
Funding: 99999.97
Reference: AC19/00124
Duration: 01/01/2020 - 30/06/2024

Related news

The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Related professionals

Arevalo Bernabé, Angel

Arevalo Bernabé, Angel

Predoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Llaurado Dalmau, Maria Pilar

Llaurado Dalmau, Maria Pilar

Multidisciplinary Nursing Research Group
Read more
Marti Martinez, Sheila

Marti Martinez, Sheila

Shock, Organ Dysfunction and Resuscitation
Read more
Valero Dominguez, Daniel

Valero Dominguez, Daniel

Ophtalmology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.